Geneos Wealth Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$88.1K Sell
546
-342
-39% -$55.2K ﹤0.01% 1300
2025
Q1
$151K Buy
888
+562
+172% +$95.6K ﹤0.01% 1358
2024
Q4
$54.2K Sell
326
-109
-25% -$18.1K ﹤0.01% 1283
2024
Q3
$74.8K Hold
435
﹤0.01% 1054
2024
Q2
$67K Hold
435
﹤0.01% 976
2024
Q1
$66.9K Sell
435
-73
-14% -$11.2K ﹤0.01% 972
2023
Q4
$80.3K Hold
508
﹤0.01% 903
2023
Q3
$74.3K Buy
508
+50
+11% +$7.32K ﹤0.01% 962
2023
Q2
$70.1K Sell
458
-2
-0.4% -$306 ﹤0.01% 977
2023
Q1
$71.3K Hold
460
﹤0.01% 958
2022
Q4
$70.9K Hold
460
﹤0.01% 928
2022
Q3
$60K Sell
460
-260
-36% -$33.9K ﹤0.01% 966
2022
Q2
$100K Hold
720
﹤0.01% 1007
2022
Q1
$107K Sell
720
-428
-37% -$63.6K ﹤0.01% 1062
2021
Q4
$185K Sell
1,148
-250
-18% -$40.3K 0.01% 903
2021
Q3
$231K Sell
1,398
-75
-5% -$12.4K 0.01% 803
2021
Q2
$255K Sell
1,473
-12,712
-90% -$2.2M 0.01% 752
2021
Q1
$2.33M Buy
14,185
+498
+4% +$81.7K 0.07% 269
2020
Q4
$264K Buy
13,687
+11,893
+663% +$229K 0.01% 733
2020
Q3
$278K Buy
1,794
+124
+7% +$19.2K 0.01% 578
2020
Q2
$279K Buy
1,670
+218
+15% +$36.4K 0.02% 566
2020
Q1
$185K Sell
1,452
-296
-17% -$37.7K 0.01% 637
2019
Q4
$261K Sell
1,748
-518
-23% -$77.3K 0.01% 597
2019
Q3
$279K Sell
2,266
-1,307
-37% -$161K 0.02% 551
2019
Q2
$503K Buy
3,573
+49
+1% +$6.9K 0.03% 401
2019
Q1
$531K Buy
3,524
+916
+35% +$138K 0.04% 381
2018
Q4
$316K Buy
2,608
+801
+44% +$97.1K 0.02% 472
2018
Q3
$286K Buy
1,807
+185
+11% +$29.3K 0.02% 527
2018
Q2
$227K Sell
1,622
-185
-10% -$25.9K 0.02% 536
2018
Q1
$240K Buy
1,807
+527
+41% +$70K 0.02% 487
2017
Q4
$159K Sell
1,280
-15
-1% -$1.86K 0.01% 598
2017
Q3
$160K Sell
1,295
-314
-20% -$38.8K 0.02% 573
2017
Q2
$183K Sell
1,609
-44
-3% -$5K 0.02% 518
2017
Q1
$174K Buy
1,653
+983
+147% +$103K 0.02% 517
2016
Q4
$60K Buy
670
+202
+43% +$18.1K 0.01% 771
2016
Q3
$46K Hold
468
0.01% 845
2016
Q2
$42K Sell
468
-50
-10% -$4.49K 0.01% 864
2016
Q1
$46K Buy
+518
New +$46K 0.01% 817